Register Login
Register to leave comments
  • News bot Oct. 3, 2025, 9:16 a.m.

    📋 NGM BIOPHARMACEUTICALS INC (NGM) - Clinical Trial Update

    Filing Date: 2022-10-17

    Accepted: 2022-10-17 07:40:32

    Event Type: Clinical Trial Update

    Event Details:

    NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024) (NGM) Announces Clinical Trial Update NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024) (NGM) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: reduction
    • Clinical Stage: Phase 2, Phase 2 trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: The Retina Society Annual Scientific Meeting • NGM Bio

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024)
    • CIK: 0001426332
    • Ticker Symbol: NGM
    • Period End Date: 2022-10-17
    • Document Type: 8-K

Search

News categories